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To prevent potentially damaging inflammatory responses, the eye actively promotes local immune tolerance via a variety of mechanisms. Owing to trauma, infection, or other ongoing autoimmunity, these mechanisms sometimes fail, and an autoimmune disorder may develop in the eye. In mice of the C57BL/10 (B10) background, autoimmune keratitis often develops spontaneously, particularly in the females. Its incidence is greatly elevated in the absence of gd T cells, such that ∼80% of female B10. A lthough immune responses are beneficial in clearing the host of infectious microbes, they also can cause collateral tissue damage that threatens the function of organs, and in the eye, a vigorous immune response can jeopardize the vision of the host. For this reason, immune responses in the eye are dampened by a variety of mechanisms that collectively are referred to as ocular immune tolerance. gd T cells have been shown in several experimental systems to be important for the development of ocular immune tolerance. They are necessary for the phenomenon of anterior chamber-associated immune deviation (ACAID), in which Ag initially introduced into the anterior chamber of the eye induces systemic immune tolerance, because both TCRd 2/2 mice and mice treated with an Ab that blocks the gd TCR failed to develop ACAID (1, 2). As well, corneal transplant allografts, which, because of ocular immune privilege, are generally accepted even when they originate from histoincompatible donors, were rejected in mice pretreated with anti-gd TCR Ab (1) . However, gd T cells conversely can play a role in immune protection in the eye; in mice infected with HSV-1 by an ocular route, gd T cells were able to reduce epithelial lesions and prevent the subsequent development of lethal viral encephalitis (3) . A series of recent reports indicated that gd T cells that reside in the eye in fact walk a fine line between promoting inflammation and enhancing healing (4) (5) (6) . These gd T cells, which make up .90% of the T cells normally present in the limbal epithelium of the eye, clearly mediate wound healing but also promote neutrophil infiltration and subsequent platelet deposition (4) . Despite the proinflammatory potential of the gd T cells infiltrating the wounded cornea, which are CCR6 + and IL-17 + (5) , inflammatory damage appears to be mitigated by their coproduction of IL-22 (6) . This cytokine, which, like IL-17, mobilizes neutrophils, also protects against inflammatory tissue destruction by promoting regeneration of damaged epithelia and stimulating epithelial cells to secrete antimicrobial peptides (7) . Importantly, topical treatment of the cornea with recombinant IL-22 functionally replaced the gd T cells in their ability to promote corneal wound healing (6) . Thus, a variety of experimental models revealed that gd T cells are critical players during immune responses in the eye.
Likewise, many papers have been published regarding regulatory T cells (Tregs) that are important in maintaining ocular immune tolerance and are needed for the development of ACAID. In addition to gd T cells (1, 2) , at least two distinct ab TCR + regulatory subsets, one CD4 + and one CD8 + , have long been recognized (8, 9) . Whether or not the CD4 + regulatory cells in ACAID represent classical adaptive CD4 + CD25 + Foxp3 + Tregs is somewhat controversial, because although they were found to be CD25 + IL-10 producers in one study (10) , in another, the CD4 + regulatory cells appeared to be able to develop from CD25 2 precursors (11).
However, CD4 + CD25 + Foxp3 + IL-10-producing Tregs with suppressive capacity clearly increase in the spleens of mice with ACAID (12) and appear to be part of the process that brings about ocular immune tolerance. In one study, gd T cells appeared to be needed to produce the IL-10 required for generation of CD8 + regulatory cells that help bring about ACAID (13) . gd T cells have also been found to promote the development of autoimmune uveitis by enhancing the activation of uveitogenic ab T cells (14, 15) .
We noted in previous studies that spontaneous keratitis develops at a high rate in female C57BL/10 (B10) mice that lack gd T cells (B10.TCRd 2/2 mice), implying that gd T cells normally promote immune regulation in the cornea of B10 mice (16, 17) . Approximately 80% of female B10.TCRd 2/2 mice show overt keratitis by 18 wk of age, whereas the rate among males of this age is only ∼15%. Despite the large difference between genders, we found no evidence that female hormones promote keratitis (17) , or that male hormones protect against it (16) . ab T cells, in contrast, promoted the development of the disease, suggesting that it is autoimmune mediated, whereas adoptive transfer of wild-type gd T cells into B10.TCRd 2/2 hosts decreased its incidence (16) . We failed to detect any infectious component contributing to the disease, and rederived B10.TCRd 2/2 mice developed keratitis at a rate similar to that of the original strain, supporting the interpretation that the disease arises from an autoimmune attack (16) . B cells do not appear to contribute to the development of keratitis (17 
Materials and Methods
Mice C57BL/10 J (B10) mice were originally obtained from The Jackson Laboratory and thereafter maintained in our facility. All mice were housed under specific pathogen-free conditions. B10.TCRd 2/2 and B10.TCRb/ d 2/2 mice were established in our facility as previously described (16) . All experiments were conducted under a protocol approved by the Institutional Animal Care and Use Committee.
Keratitis scoring
Briefly, mice were examined once per week and each eye was scored for disease severity, on a scale of 0 (no keratitis) to 5 (very severe keratitis), as has been previously described (16) . Scores for each eye were added together for a total score; the maximum possible disease score for a given mouse was therefore 10.
Corneal cell preparation
After cutting eyes in half and removing the lens, corneas were placed in a small amount of balanced salt solution (BSS) (18) under a dissecting microscope and dissected away from other eye tissue, using a scalpel. Corneas were then placed in BSS containing 0.25 mg/ml Liberase DH (Roche Diagnostics, Indianapolis, IN) and incubated on a rotator at 37˚C for 1-2 h. When the corneal structure appeared to have largely disintegrated, cells were diluted by adding 5-10 volumes of BSS + 5% FCS, and then passed through a 70-mm cell strainer (Becton Dickinson, Franklin Lakes, NJ) to remove any debris or large aggregates remaining. The cells were then pelleted by centrifugation at 1200 rpm for 8 min and used in staining experiments.
Flow cytometry
See Supplemental Table I for a list of mAbs used in this study. To block nonspecific binding via Fc receptors, cells were pretreated with 10 mg/ml mAb 2.4G2 (19) for 15 min at 4˚C before staining. Cell surface staining was carried out as previously described (20) . For intracellular cytokine staining, cells were first activated for 4-6 h with PMA/ionomycin in the presence of brefeldin A, as previously described (21); after activation, cells were washed and surface stained, and then fixed, permeabilized, and stained for intracellular cytokines. Lymphocytes were gated as previously described (22) . Flow cytometry data were analyzed using FlowJo 9.3.1 for Mac software (TreeStar, Ashland, OR).
Adoptive transfer
For CD8 + adoptive transfers, cells were purified from the spleens of B10.TCRd 2/2 or B10 donor females; spleens were dissociated in BSS + 5% FCS, using a stainless steel screen mesh, the cells were placed on ice and the debris was allowed to out settle out for a few minutes, and the cells were then pelleted by centrifugation. After lysis of RBCs using Gey's solution, the cells were washed and resuspended in BSS + 5% FCS, then passed over nylon wool columns as previously described (23) . The nonadherent cells were then blocked by incubation with an Ab against FcR II/III [clone 2.4G2 (19) ] at 10 mg/ml for 15 min at 4˚C, then washed one time, followed by treatment with biotinylated anti-CD8a or biotinylated antiCD8b mAb, as indicated in the figures, for 15 min at 4˚C. After one wash, the cells were next incubated with MACS streptavidin microbeads (Miltenyi Biotec, San Diego, CA) and passed over a MACS MS minicolumn mounted on a magnet, according to the manufacturer's instructions, to purify the positive cells. In some experiments, after removing the column from the magnetic field to elute the bound cells, they were passed again over a second MS column mounted on a magnet, then removed from the magnetic field and the bound cells were again eluted, to improve the purity of the cells. The purity of the final preparations was verified by flow cytometric analysis using streptavidin-allophycocyanin and anti-TCRb-PE mAbs; in all experiments shown, 90-95% of the purified lymphocytes were CD8 + T cells. In some experiments, CD8b + spleen cells alternatively were stained with fluorescently labeled anti-CD8b mΑb and purified using a MoFlo flow cytometer. Cells to be transferred were resuspended in BSS + 5% FCS, or BSS only, and kept on ice until ready to be injected. CD8 + cells, 1-10 3 10^5 per mouse, were transferred into 7-to 10-wk-old B10.TCRb/d 2/2 females by i.v. injection via the tail vein, in a volume of 0.1 cc; sham-treated controls were injected at the same time with an equal volume of BSS + 5% FCS, or BSS only. Mice were afterward scored weekly for keratitis for the time indicated in individual figures. CD4 + T cell adoptive transfers were carried out in a similar fashion as the CD8 + T cell adoptive transfers, but using instead a biotinylated anti-CD4 mAb plus MACS streptavidin beads, passing the cells twice over MACS MS minicolumns to improve purity. The purity of the final preparations was verified by flow cytometric analysis using streptavidin-APC and anti-TCRb-PE mAbs; in all experiments shown, $90% of the cells were CD4 + T cells. Cells to be transferred were resuspended in BSS + 5% FCS and kept on ice until ready to be injected. CD4 + cells, 1.9-3.8 3 10^5 per mouse, were transferred into 6-to 11-wk-old B10.TCRb/d 2/2 females by i.v. injection; sham-treated controls received the same volume of BSS + 5% FCS.
For Treg adoptive transfers, CD4 + cells were purified from the spleens of B10 female donors by staining with anti-CD4-FITC or -eFluor 450, together with biotinylated anti-CD25 plus streptavidin-allophycocyanin, using a MoFlo flow cytometer. The degree of purity of the sorted cells was ascertained by postsort analysis of the cells; preparations were $95% pure in all experiments. A total of 0.5 -0.9 3 10^6 cells per mouse, or an equal volume of BSS only for sham-treated controls, were injected into each host by i.v. injection, as described above, 6 d prior to CD8 + T cell adoptive transfer. B10.TCRb/d 2/2 females at 6-9 wk of age were used as recipients. Treg adoptively transferred mice, or sham-treated controls, received purified CD8 + cells from B10.TCRd 2/2 female donors 6 d later. The CD8 + cells were prepared and administered as described above, using a flow cytometer; ∼1 3 10^6 cells per mouse were transferred. Mice were scored weekly for keratitis for the times shown in Fig. 4 . total cell numbers, two-tailed unpaired t tests were carried out, assuming parametric data. For comparing the incidence of keratitis between two groups, results of a 2 3 2 contingency table were analyzed using a twotailed Fisher exact test. For comparing average keratitis scores (which are assigned ranks rather than quantitative values), differences were analyzed with a nonparametric one-tailed Wilcoxon rank sum or Mann-Whitney U test. The following symbols used in the figures correspond to p values as shown: *p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001.
Results

CD8
+ , but not CD4 + , ab T cells are sufficient to transfer the disease
In a previous study, we showed that the incidence of keratitis in B10.TCRb/d 2/2 females, which are able to produce neither ab nor gd T cells and normally have a low incidence of keratitis [∼20% develop keratitis by 18 wk of age (16)], is increased following adoptive transfer of the mice with ab T cells from the spleens of keratitic B10/TCRd 2/2 females (17). We therefore went on to compare CD4 + ab T cells and CD8 + ab T cells for their ability to transfer the disease. We found that whereas the transfer of CD4 + cells from keratitic B10.TCRd 2/2 donors had little or no effect ( Fig. 1A) , both the incidence and the severity of keratitis were markedly increased following adoptive transfer of CD8 + cells (Fig. 1B) . We used a CD8a-specific mAb to purify the donor cells from the spleen, and although our cell preparations contained $95% CD3 + TCRb + CD8a + T cells, other CD8a + cells, including a subset of dendritic cells (24) , were likely present at low levels. Because such contaminating cells might instead or as well be needed to transfer the disease, we repeated this experiment using an anti-CD8b mAb to purify CD8 + TCR-ab + T cells, which express CD8ab heterodimers (24) , from the B10.TCRd Although most are disease resistant, a low percentage (∼10%) of wild-type B10 female mice develop keratitis as well, but the disease usually remains very mild. Unlike in B10.TCRd 2/2 mice, the disease in B10 mice appears at a relatively young age (by 7 wk) and does not become more common with increasing age (16) . We therefore wondered whether pathogenic CD8 + ab T cells can develop only in mice lacking gd T cells, or instead are also present in mature wild-type mice but are less likely to cause disease in that setting. To test this, we adoptively transferred into B10.TCRb/d2/2 female hosts purified CD8 + T cells from B10 wild-type female donors and compared them with hosts that instead received an equivalent dose of CD8 + cells from B10.TCRd 2/2 female donors.
Although the disease developed somewhat more slowly in mice that received B10-derived cells, all mice in both groups developed keratitis within 6 wk after transfer (Fig. 1D) . The severity of the disease was diminished in recipients that were given B10 CD8 + cells compared with those given B10.TCRd 2/2 CD8 cells (Fig. 1E ).
This result suggests that pathogenic CD8 + T cells do not require the absence of gd T cells to develop, although a consequence of the absence of gd T cells can be that pathogenic CD8 + ab T cells are able to expand and/or become more active, increasing the chance of an autoimmune attack on the cornea.
CD8 + T cells infiltrate the corneas of keratitic mice
The eye is an immune-privileged site, owing in part to a lack of blood vessels in the cornea (a component of the blood/ocular barrier), which makes it unlikely that lymphocytes come into contact with corneal Ags (25) . A lack of the gd T cells that normally reside in the limbus surrounding the cornea could make this site more penetrable to blood-borne lymphocytes in B10.TCRd controls was seen, but this was not statistically significant (Fig. 2C, left) , and because a similar difference was apparent in keratitis-resistant B6.TCRd 2/2 females compared with B6 female controls, this finding did not suggest a potential pathologic effect. However, despite the decrease in total CD8 + ab T cells, a substantial increase in the relative frequency of both CD8 + TCM and CD8 + TEM was evident in female B10.TCRd 2/2 mice compared with B10 age-and sex-matched controls (Fig. 2C, right) . Of interest, these differences were not evident in B6.TCRd 2/2 females compared with matched B6 females, although similar differences in CD8 memory phenotype cells were found in B10.TCRd 2/2 male mice of the same age compared with matched B10 male controls (see Supplemental Fig. 1A ). The higher frequency of memory phenotype CD8 + T cells in keratitis-susceptible B10.TCRd 2/2 mice, despite an overall decrease in CD8 + T cell numbers in this strain compared with B10 controls, is even more striking in light of the fact that such differences were already clear when the mice were only 5 wk old, at which time almost none have developed keratitis. We therefore went on to test how the TCM and TEM ab T cells in B10 versus B10.TCRd 2/2 mice compared in older animals in which keratitis either had or had not developed. As can be seen (Fig. 2D) mice is biased to produce inflammatory cytokines
We went on to look at the cytokines produced by CD8 + T cells in B10.TCRd 2/2 females and found that an elevated percentage produce IFN-g and TNF-a when nonspecifically stimulated, compared with matched B10 controls (Fig. 3) . In contrast, the percentage producing these two cytokines was not different in the CD4 + T cells from B10.TCRd 2/2 mice versus those from B10.
This finding is consistent with the idea that it is the CD8 + T cells that promote keratitis in B10.TCRd 2/2 mice. Interestingly, among both CD8 + and CD4 + cells from B10.TCRd 2/2 mice, there was also .2-fold reduction in the percentage biased to produce IL-2, compared with the same cells in B10 controls (Fig. 3, left) . Although IL-2 can boost proinflammatory effector T cells and is required for their responses, IL-2 is also essential for the development of adequate numbers of Tregs, including CD4 + CD25 + Foxp3 + Tregs (27) . Thus, the low percentage of ab T cells in B10.TCRd 2/2 mice that are able to produce IL-2 could lead to a deficiency in Tregs in these mice.
Tregs can reduce CD8 T cell-transferred keratitis
To test whether inadequate Treg numbers could explain the susceptibility to keratitis in B10. Fig. 4 , we found that mice that also received Tregs showed a delayed onset of the disease and reduced disease incidence. This observation was true for mice that initially received nearly as many CD4 + Tregs in the initial transfer as they did CD8 + T cells in the second transfer (Fig. 4, left) , as well as for mice that received only half as many CD4 + Tregs as CD8 + T cells (Fig. 4, right) + TCRb + CD8 + spleen cells (right), the proportion having the T effector memory phenotype (TEM) was determined as those cells staining brightly with anti-CD44 and dimly with anti-CD62L. The proportion having the T central memory cell phenotype (TCM) was determined as those cells staining brightly for both CD44 and CD62L. For each group, data were averaged from three to six 5-wk-old mice. (D) As for (C), except that 6-10 females aged 18-30 wk were used to calculate averages. (E) Representative flow cytometry plots of samples analyzed in (A) and (B), including the gating strategy used to test for memory phenotype ab T cells. *p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001. in the B10.TCRd 2/2 females, these Tregs were indeed found to be significantly reduced, in terms of both percent and absolute numbers (Fig. 5B) . CD4 + Tregs were similarly reduced in B10.TCRd 2/2 males versus B10 male controls (see Supplemental (Fig. 5B) . Moreover, in older B10.TCRd 2/2 females, the numbers and frequencies of CD4 + Tregs remained low, and were even more reduced in those with keratitis, when compared with either matched wild-type controls or matched nonkeratitic B10.TCRd 2/2 females (Fig. 5C ). We went on to examine the levels of two molecules present on Tregs that are important for their functionality: IL-2Ra (CD25) and IL-2Rb (CD122) (29) . As can be seen (Fig. 5D) (Fig. 5E ). These data imply that the lack of gd T cells in B10.TCRd 2/2 mice in some way disrupts the development of ab Tregs. Because Treg deficiencies were found in mice that have a strong tendency to develop keratitis, but not in those that do not, they may explain the increased survival and/or expansion of memory phenotype CD8 + T cells in these mice. 
Discussion
In this study, we discovered three abnormalities in the ab T cells of keratitis-prone B10. pression of CD25 (IL-2Ra) and CD122 (IL-2Rb) revealed that they carry lower surface levels of these receptors than do Tregs from wild-type B10 mice, particularly those taken from keratitic mice (Fig. 5D, above) . IL-2 receptors are clearly important for the functional differentiation and maintenance of CD4 + Tregs (33) and may be necessary for their activation or suppressive activity as well (29) . Moreover, we also found that both CD4 + and CD8 + T cells in B10.TCRd 2/2 mice produce substantially less IL-2 than do those in B10 controls. These three findings together-reduced CD4 + Treg cell numbers, reduced levels of IL-2Ra and IL-2Rb on the Tregs, and a lower frequency of CD4 and CD8 T cells biased to produce IL-2-suggest that Treg influence could be substantially impaired in B10.TCRd 2/2 mice.
Because we backcrossed the Cd-null mutation (34) versus B10 mice is that the latter also contain a few contaminating gd T cells, because ∼15% normally express CD8 (36) , and this could instead explain why CD8 + T cells from B10 mice were comparatively less efficient in transferring disease. However, gd T cells compete poorly with CD8 + ab T cells in homeostatic proliferation following adoptive transfer (37, 38) , and when we examined the composition of the transferred cells 3 wk later (Supplemental Fig. 2A) , essentially all CD8 + T cells in the spleen were ab TCR + cells, whereas gd T cells (CD3 + TCRb 2 cells)
could not be detected. Therefore, it seems unlikely that contaminating gd T cells had much, if any, effect in this experiment. We found that the adoptively transferred CD8a + cells, after homeostatic expansion, also virtually all displayed a memory phenotype in spleen, lymph node, and blood, representing either TCM (CD44-high, CD62L-high) or TEM (CD44-high, CD62L-low) cells (Supplemental Fig. 2B) these ab T cell abnormalities. Instead, some other factor peculiar to the B10 background is also needed that, together with the lack of gd T cells, predisposes the mice to develop these defects, which together with a characteristic found in the females, further predisposes the majority of them to spontaneously develop autoimmune keratitis. The decrease in CD4 + Tregs could, however, directly give rise to increased survival of CD8 memory cells, which could in turn reduce the overall number of CD8 + cells-the other two ab T cell abnormalities that were evident in B10.TCRd 2/2 mice. B10 mice differ genetically from B6 mice at only a few loci, one of which, the Lv locus, was previously implicated in the greater resistance of B10 mice to infection with the pathogenic fungus Coccidioides immitis, compared with B6 (40), so it is possible that the Lv locus is also key in keratitis susceptibility.
Our finding in this study that CD8 + T cells are sufficient to induce spontaneous autoimmune keratitis represents a relatively rare example in which it has been shown that CD8 + T cells alone, but not CD4 + cells, are responsible for the autoimmunity (reviewed in Ref. 41 ). Although CD8 + T cells are able to transfer autoimmunity in a mouse model of type 1 diabetes (NOD mice) and of multiple sclerosis (experimental autoimmune encephalomyelitis), in both cases, CD4 + T cells were also able to transfer the disease. However, there is clear evidence that CD8 + T cells mediate disease in patients with vitiligo (42, 43) , and CD8 + T cells may also be critical in Hashimoto's thyroiditis (44) . The CD8 + T cell requirement we found in our model could be a consequence of immune mechanisms unique to the eye, although in keratitis induced by Candida albicans infection, the disease was dependent upon IL-17-producing CD4 + T cells, and in herpes stromal keratitis, CD4 + T cells were also found to play a necessary role as an autoimmune component (45) .
The ability to produce IL-10 is required for gd T cells that promote the development of ACAID (13) . Whether IL-10 produced in part by gd T cells is likewise critical for producing CD4 + Tregs that prevent autoimmune keratitis in our system has yet to strain. To examine this possibility, we therefore compared purified ab T cells from the spleens of B10 mice with gd T cells for their ability to produce IL-2, following nonspecific activation in vitro. Splenic gd T cells in fact produced much less IL-2 than did splenic ab T cells (see Supplemental Fig. 3A) . However, when we similarly examined IL-2 production by gd T cells isolated from the thymus (Supplemental Fig. 3B ), they produced IL-2 in amounts comparable to those produced by gd TCR-negative thymocytes. Moreover, when we nonspecifically activated thymocytes and then compared thymic gd TCR + cells with ab TCR + cells present in the same cultures, a similar percentage in each group was positive for IL-2 by intracellular cytokine staining (Supplemental Fig. 3C ). Thus, a reduction in IL-2 in the thymus owing to the lack of gd T cells is a possible mechanism to explain why Tregs are reduced in B10.TCRd 2/2 mice. If, in B10 mice, gd T cells normally provide a significant fraction of the limiting amount of IL-2 necessary for the thymic development of CD4 + CD25 + Tregs (33), the lack of this additional IL-2 source could diminish the levels of Tregs coming out of the thymus and lead to reduced peripheral Tregs as well. As noted above, thymic Tregs were in fact also substantially reduced in B10.TCRd 2/2 mice (Fig. 5E ).
Different gd T cell subsets, which can be partially defined by the TCRs they express, are biased to produce certain cytokines, usually including either IFN-g or IL-17 (47, 48) . gd T cells that reside in the limbus of the eye are known to promote healing in a corneal wounding model and have been shown to secrete both IL-17 and IL-22 (4, 6), both neutrophil-mobilizing cytokines. Whether these IL-17-producing gd T cells are the same gd T cells that in B10 mice promote the development of CD4 + Tregs and prevent autoimmune keratitis therefore seems unlikely. A previous experiment suggested that the protective gd T cells in our model express Vg1 (17) . We have yet to determine whether Vg1 + cells are capable of promoting the development of CD4 + CD25 + Foxp3 + Tregs and, if so, how they may accomplish this.
